Momentum is continuing to build at Vitura Health, its chief executive has said, after the company delivered its third dividend to shareholders in four years.
The company this week paid investors A$1.32 million at $0.2c per share after a 2025 financial year that saw Vitura generate $124m in revenue and post a net profit after tax of $3.1m.
Cockerill said the business is continuing to make progress, with recent acquisitions giving it access to thousands more patients.
“We have a new leadership team, which has been executing well against our strategic reset, and integration of our acquisitions continues,” he said.
“In November 2024 we acquired assets of Releaf Group giving us access to 30,000 additional patients. In February 2025 our acquisition of Candor Medical added 15,000 patients and in May this year we acquired assets of Heyday Medical driving further growth.
“Our focus remains on disciplined growth and long-term value creation. We are building a resilient business that delivers for patients, partners, and shareholders alike.”
Vitura, then Cronos Australia, paid its first dividend in FY22 and again in FY23 before a tough FY24 resulted in no shareholder payout.